Veloxis Announces Scientific Publication of Phase II Study Demonstrating Conversion from Twice-Daily Tacrolimus to Once-Daily Envarsus® in Liver Transplant Patients

Source: Medical News (via PRIMEZONE) - Category: Pharmaceuticals Source Type: news